These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22790958)

  • 1. Establishment of a monitoring system to detect inhibition of mRNA processing.
    Fujita K; Okamura M; Nishimoto S; Kurihara T; Momma K; Miyamae Y; Kambe T; Nagao M; Narita H; Masuda S
    Biosci Biotechnol Biochem; 2012; 76(6):1248-51. PubMed ID: 22790958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation.
    Roybal GA; Jurica MS
    Nucleic Acids Res; 2010 Oct; 38(19):6664-72. PubMed ID: 20529876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A.
    Yoshimoto R; Kaida D; Furuno M; Burroughs AM; Noma S; Suzuki H; Kawamura Y; Hayashizaki Y; Mayeda A; Yoshida M
    RNA; 2017 Jan; 23(1):47-57. PubMed ID: 27754875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discovery of splicing inhibitors and its impact on drug development].
    Kotake Y; Kaida D; Mizui Y; Yoshida M
    Tanpakushitsu Kakusan Koso; 2008 Jan; 53(1):28-35. PubMed ID: 18186300
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of splicing and nuclear retention of pre-mRNA by spliceostatin A in fission yeast.
    Lo CW; Kaida D; Nishimura S; Matsuyama A; Yashiroda Y; Taoka H; Ishigami K; Watanabe H; Nakajima H; Tani T; Horinouchi S; Yoshida M
    Biochem Biophys Res Commun; 2007 Dec; 364(3):573-7. PubMed ID: 17961508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing inhibition induces gene expression through canonical NF-κB pathway and extracellular signal-related kinase activation.
    Khan K; Schneider-Poetsch T; Ishfaq M; Ito A; Yoshimoto R; Mukaida N; Yoshida M
    FEBS Lett; 2014 Mar; 588(6):1053-7. PubMed ID: 24561197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U2 snRNP is required for expression of the 3' end of genes.
    Koga M; Satoh T; Takasaki I; Kawamura Y; Yoshida M; Kaida D
    PLoS One; 2014; 9(5):e98015. PubMed ID: 24845214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of differential 3' splice site sensitivity to anti-tumor drugs targeting U2 snRNP.
    Vigevani L; Gohr A; Webb T; Irimia M; Valcárcel J
    Nat Commun; 2017 Dec; 8(1):2100. PubMed ID: 29235465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1.
    Pham D; Koide K
    Nat Prod Rep; 2016 May; 33(5):637-47. PubMed ID: 26812544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.
    Corrionero A; Miñana B; Valcárcel J
    Genes Dev; 2011 Mar; 25(5):445-59. PubMed ID: 21363963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.
    Kaida D; Motoyoshi H; Tashiro E; Nojima T; Hagiwara M; Ishigami K; Watanabe H; Kitahara T; Yoshida T; Nakajima H; Tani T; Horinouchi S; Yoshida M
    Nat Chem Biol; 2007 Sep; 3(9):576-83. PubMed ID: 17643111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ever-increasing complexities of the exon junction complex.
    Tange TØ; Nott A; Moore MJ
    Curr Opin Cell Biol; 2004 Jun; 16(3):279-84. PubMed ID: 15145352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of pre-mRNA splicing by antisense oligonucleotides.
    Kole R
    Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome.
    Agranat-Tamir L; Shomron N; Sperling J; Sperling R
    Nucleic Acids Res; 2014 Apr; 42(7):4640-51. PubMed ID: 24464992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splicing modulators elicit global translational repression by condensate-prone proteins translated from introns.
    Chhipi-Shrestha JK; Schneider-Poetsch T; Suzuki T; Mito M; Khan K; Dohmae N; Iwasaki S; Yoshida M
    Cell Chem Biol; 2022 Feb; 29(2):259-275.e10. PubMed ID: 34520743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spliceostatin A treatment inhibits mitotic clonal expansion and adipogenesis.
    Kaida D
    Biochem Biophys Res Commun; 2019 Jun; 514(3):848-852. PubMed ID: 31079922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudemycin K: A Synthetic Antitumor Splicing Inhibitor Variant with Improved Activity and Versatile Chemistry.
    Makowski K; Vigevani L; Albericio F; Valcárcel J; Álvarez M
    ACS Chem Biol; 2017 Jan; 12(1):163-173. PubMed ID: 28103691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF.
    Furumai R; Uchida K; Komi Y; Yoneyama M; Ishigami K; Watanabe H; Kojima S; Yoshida M
    Cancer Sci; 2010 Nov; 101(11):2483-9. PubMed ID: 20726856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spliceostatin A interaction with SF3B limits U1 snRNP availability and causes premature cleavage and polyadenylation.
    Yoshimoto R; Chhipi-Shrestha JK; Schneider-Poetsch T; Furuno M; Burroughs AM; Noma S; Suzuki H; Hayashizaki Y; Mayeda A; Nakagawa S; Kaida D; Iwasaki S; Yoshida M
    Cell Chem Biol; 2021 Sep; 28(9):1356-1365.e4. PubMed ID: 33784500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.